Section Arrow
CLPT.NASDAQ
- ClearPoint Neuro
Quotes are at least 15-min delayed:2026/03/12 02:21 EDT
Regular Hours
Last
 11.62
+0.3 (+2.65%)
Day High 
11.8754 
Prev. Close
11.32 
1-M High
15.2592 
Volume 
564.47K 
Bid
11.5
Ask
11.55
Day Low
11.39 
Open
11.44 
1-M Low
8.63 
Market Cap 
336.75M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 11.18 
20-SMA 12.55 
50-SMA 13.53 
52-W High 30.0999 
52-W Low 8.63 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.83/-0.08
Enterprise Value
339.76M
Balance Sheet
Book Value Per Share
0.53
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
31.39M
Operating Revenue Per Share
0.73
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp69.63-0.33-0.47%36.06PE
ABTAbbott Laboratories110.25-0.3-0.27%29.72PE
MDTMedtronic plc88.97-0.92-1.02%25.14PE
PACBPacific Biosciences of California1.35-0.015-1.10%-- 
EWEdwards Lifesciences Corp85.09-0.69-0.80%47.39PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.